Publications by authors named "R Barua"
Ferroptosis is an iron-dependent form of controlled cell death and is characterized by the formation of lipid peroxides. Understanding gene expressions associated with ferroptosis is critical for determining its function in illnesses and potential therapeutic approaches. Despite its significance, no computational model is currently available to accurately quantify the ferroptosis incident.
View Article and Find Full Text PDFArticle Synopsis
- Edible and medicinal mushrooms are highly nutritious and versatile, making them valuable for various biotechnological applications, especially in processing agricultural waste in an eco-friendly way.
- The review explores how these mushrooms can enhance food quality and flavor, and highlights their utility in cosmeceuticals, biomedicine, bioethanol production, and soil decontamination.
- The growing interest in these mushrooms is due to their potential as a natural source of novel bioactive compounds, aligning with sustainability and circular production models.
The ternary transition metal boride FeAlB is a unique ferromagnetic "MAB" phase that demonstrates a sizable magnetocaloric effect near room temperature-a feature that renders this material suitable for magnetic heat pump devices (MHP), a promising alternative to conventional vapor compression technology. Here, we provide a comprehensive review of the material properties of FeAlB (magnetofunctional response, transport properties, and mechanical stability) and discuss alloy synthesis from the perspective of shaping these materials as porous active magnetic regenerators in MHPs. Salient aspects of the coupled magnetic and structural phase transitions are critically assessed to elucidate the fundamental origin of the functional response.
View Article and Find Full Text PDFIn the present work, phytoconstituents from Citrus limon are computationally tested against SARS-CoV-2 target protein such as Mpro - (5R82.pdb), Spike - (6YZ5.pdb) &RdRp - (7BTF.
View Article and Find Full Text PDFObjectives: Immune checkpoint inhibitors (ICIs) are indicated for metastatic urothelial cancer (mUC), but predictive and prognostic factors are lacking. We investigated clinical variables associated with ICI outcomes.
Methods: We performed a multicentre retrospective cohort study of 135 patients who received ICI for mUC, 2016-2021, at three Canadian centres.